82. Validation (14): Prevention of Cellular AD Pathology in Human Neuronal Cell-Based AD Models by Limited Editing of the 5′ Terminus of AβPP mRNA or via the Employment of Anti-Antisense Oligonucleotides. Here, APP is linked to Alzheimer disease.